LogicBio Therapeutics, Inc.
DelistedCIK 1664106fmd_0HA1TCX7KW24FKD35X15XR6YF4Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Sep 30, 2022, 22 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | – | – | – | 3 | 5 |
| Research and development | 4 | 11 | 31 | 23 | 28 |
| Total operating expenses | 6 | 18 | 41 | 35 | 44 |
| Operating income | (6) | (18) | (41) | (32) | (39) |
| Interest expense | – | 0 | 1 | 1 | 1 |
| Other non-operating income (expense) | 0 | 0 | 1 | (1) | (1) |
| Income before taxes | (6) | (18) | (40) | (32) | (40) |
| Income tax expense | 0 | 0 | 0 | 0 | (0) |
| Net income from continuing operations | (6) | (18) | (40) | (33) | (40) |
| Net income | (6) | (18) | (40) | (33) | (40) |